OHC is the only adult cancer practice in the region to offer the revolutionary immunotherapy treatment, CAR-T, for adults, ushering in a new frontier in the fight against cancer.

OHC is an American Society of Clinical Oncology Clinical Trial Award Winner for its dedication to conquering cancer worldwide by funding breakthrough cancer research and sharing cutting-edge knowledge.

OHC is a partner with US Oncology Research and connects OHC and our patients to an experienced network of more than 900 dedicated researchers and access to more than 400 Phase 1 – 4 clinical trials.

OHC is one of only six community oncology practices in the country that has been recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology for its commitment to high quality clinical trial programs.

OHC doctors serve as Medical Director of the nationally-recognized, FACT-accredited Blood and Marrow Transplant Program at The Jewish Hospital – Mercy Health. The hospital’s program has earned The Joint Commission’s prestigious Gold Seal of Approval.

OHC is certified by the American Society of Clinical Oncology (ASCO) in the Quality Oncology Practice Initiative Certification Program (QOPI) for achieving rigorous standards for high quality cancer care.

The OHC Specialty Pharmacy is accredited by the Accreditation Commission for Health Care (ACHC). By achieving this distinction, the OHC Pharmacy is able to demonstrate its commitment to providing the highest-quality service through compliance with national regulations and industry best practices.

OHC is one of only a select few cancer practices nationally to be accepted to participate in the Oncology Care Model, part of The Center for Medicare and Medicaid Innovation Center.

OHC is an accredited Oncology Medical Home, which focuses on delivering, ensuring, and measuring quality cancer care and relies on a doctor-led, team-based healthcare model that provides comprehensive and continuous care to cancer patients with a goal of obtaining maximized health outcomes.